| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/24/2008 | WO2008009615A1 Dietary supplement for supporting mental and physical performance |
| 01/24/2008 | WO2008009458A1 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| 01/24/2008 | WO2008009435A1 Amino-piperidine derivatives as cetp inhibitors |
| 01/24/2008 | WO2008009215A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 01/24/2008 | WO2008009151A1 Tannin-free extract of rhodiola rosea l |
| 01/24/2008 | WO2008009062A1 Treatment for intimal hyperplasia and related conditions |
| 01/24/2008 | WO2007139972A3 Expression of the cysteine protease legumain in vascular and inflammatory diseases |
| 01/24/2008 | WO2007139948A3 Imidazoazepinone compounds |
| 01/24/2008 | WO2007139775A3 N-methanocarba derivatives to treat cardiac diseases |
| 01/24/2008 | WO2007137040A3 7-(acryloyl) indole compositions and methods for making and using same |
| 01/24/2008 | WO2007130075A8 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| 01/24/2008 | WO2007067618A3 The use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division |
| 01/24/2008 | WO2006107902A8 Use of spirostenols to treat mitochondrial disorders |
| 01/24/2008 | WO2006029371A3 Neuromedin u 2 receptor agonists and uses thereof |
| 01/24/2008 | US20080022422 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/24/2008 | US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/24/2008 | US20080021105 Medicine Capable of Inhibiting Activation of Transcription Factor Klf5 |
| 01/24/2008 | US20080021088 Retinoid Derivatives With Antiangiogenic, Antitumoral And Proapoptotic Activities |
| 01/24/2008 | US20080021069 Receptor Function Regulating Agent |
| 01/24/2008 | US20080021062 Alkylsulphonamide Quinolines |
| 01/24/2008 | US20080021060 Quinuclidine carbamate derivatives and their use as M3 antagonists |
| 01/24/2008 | US20080021055 Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/24/2008 | US20080021052 Novel glucokinase activators and methods of using same |
| 01/24/2008 | US20080021037 Isethionate salt of a selective cdk4 inhibitor |
| 01/24/2008 | US20080021030 Substituted Pyrazoles As Ppar Agonists |
| 01/24/2008 | US20080021024 Metalloprotease inhibitors |
| 01/24/2008 | US20080021022 (5-(4-Chlorophenyl)isoxazol-4-yl)(3-(pyridin-3-yl)pyrrolidin-1-yl)methanone; enzyme inhibitor of Hydroxysteroid dehydrogenases; treatment of diabetes, obesity |
| 01/24/2008 | US20080021018 (S)-(-)-1-(4-Fluoroisoquinolin-5-Yl)Sulfonyl-2-Methyl-1,4-Homopiperazine Hydrochloride Dihydrate |
| 01/24/2008 | US20080021017 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 01/24/2008 | US20080021007 Substituted Porphyrins |
| 01/24/2008 | US20080021005 Pegylated Ion Channel Modulating Compounds |
| 01/24/2008 | US20080020988 Brain cell- or nerve cell-protecting agents comprising medicinal ginseng |
| 01/24/2008 | US20080020983 Peptides with antioxidant and antimicrobial properties |
| 01/24/2008 | US20080020977 Use of Fullerenes to Oxidize Reduced Redox Proteins |
| 01/24/2008 | US20080020971 Heptanoic acid derivatives as dipeptidyl peptidase inhibitors |
| 01/24/2008 | US20080020970 For promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 01/24/2008 | US20080020965 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080020459 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 01/24/2008 | US20080020063 Anti-angiogenic compositions and methods of use |
| 01/24/2008 | US20080020021 5-Hydroxysapogenin derivatives with anti-dementia activity |
| 01/24/2008 | US20080020018 Combination Products |
| 01/24/2008 | US20080020014 Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders |
| 01/24/2008 | US20080019997 Therapeutic uses of dunaliella powder |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080019978 nicotinic receptor agonist useful for treating metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastrointestinal diseases, diabetes, and non-alcoholic fatty liver diseases |
| 01/24/2008 | US20080019975 Novel Regimens for Treating Diseases and Disorders |
| 01/24/2008 | US20080019963 Antibodies, polypeptides and uses thereof |
| 01/24/2008 | US20080019953 contacting a myocardial cells with genetic engineered mammalian cells modified to express a connexin 43 proteins, to establishing electrical coupling between cardiomyocytes and recombinant cells; treatment of cardiac disease or tissue repair |
| 01/24/2008 | US20080019922 Quinazoline derivatives, their preparation, their use, and medicaments comprising them |
| 01/24/2008 | US20080019916 Methods and pharmaceuticals for treating muscle insulin resistance and related conditions |
| 01/24/2008 | DE102007032613A1 Spiraprilhydrochlorid und polymorphe Formen davon Spirapril hydrochloride and polymorphic forms thereof |
| 01/24/2008 | DE102006034320A1 Antioxidant, useful for preparation of e.g. coloring agent, vesicle, dermocosmetic, pharmaceuticals and nutrient- or feedstuff, comprises at least an isorenieratene compound |
| 01/24/2008 | DE102006033140A1 Aminoindazolharnstoffderivate Aminoindazolharnstoffderivate |
| 01/24/2008 | CA2658352A1 Treatment for intimal hyperplasia and related conditions |
| 01/24/2008 | CA2658100A1 High-molecular weight conjugate of combretastatins |
| 01/24/2008 | CA2657269A1 New indications for direct thrombin inhibitors |
| 01/24/2008 | CA2657266A1 New indications for direct thrombin inhibitors in the cardiovascular field |
| 01/24/2008 | CA2657260A1 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| 01/24/2008 | CA2657258A1 Amino-piperidine derivatives as cetp inhibitors |
| 01/23/2008 | EP1881065A1 DINO polypetide |
| 01/23/2008 | EP1881007A1 LLR-J24 related proteins |
| 01/23/2008 | EP1880721A1 Agent for improving circulatory disorder |
| 01/23/2008 | EP1879882A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors |
| 01/23/2008 | EP1879881A2 Inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 01/23/2008 | EP1879860A2 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia |
| 01/23/2008 | EP1879610A1 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases |
| 01/23/2008 | EP1879605A2 Novel nutraceutical compositions |
| 01/23/2008 | EP1879594A2 Use of a combination of vitamins b and phytosterols for lowering blood pressure |
| 01/23/2008 | EP1807510A4 Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof |
| 01/23/2008 | EP1807505A4 Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc) |
| 01/23/2008 | EP1667635A4 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/23/2008 | EP1572679A4 Crfr1 selective ligands |
| 01/23/2008 | EP1532144B1 quinuclidine derivatives and their use |
| 01/23/2008 | EP1501801B1 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases |
| 01/23/2008 | EP1490366B1 alkoxypyridine-derivatives |
| 01/23/2008 | EP1436283B1 Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/23/2008 | EP1330451B1 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 01/23/2008 | EP1322619B1 Isoquinolinone potassium channel inhibitors |
| 01/23/2008 | EP1272178B1 Bilirubin or biliverdin degradation fragments |
| 01/23/2008 | EP1268425B1 Carbamate caspase inhibitors and uses thereof |
| 01/23/2008 | EP1246903B1 Reconstructing organs from decellularized biomaterial scaffold |
| 01/23/2008 | EP1237880B1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | EP1135498B1 Antibody variants with higher binding affinity compared to parent antibodies |
| 01/23/2008 | EP0986376B1 USE OF A FACTOR Xa INHIBITing oligosaccharide WITH A PLATELET ANTIAGGREGATING AGENT FOR TREATING ARTERIAL THROMBOSIS |
| 01/23/2008 | CN101111490A 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 01/23/2008 | CN101111488A Novel compounds |
| 01/23/2008 | CN101111480A 取代的吡啶酮衍生物 Substituted pyridone derivative |
| 01/23/2008 | CN101111266A Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 01/23/2008 | CN101111257A Methods of increasing cerebral blood flow |
| 01/23/2008 | CN101111236A Prevention and treatment of thromboembolic disorders |
| 01/23/2008 | CN101109011A Novel modified corin molecules having substitute activation sequences and uses thereof |
| 01/23/2008 | CN101108878A Glp-1 analogues |
| 01/23/2008 | CN101108875A Growth hormone releasing peptides |
| 01/23/2008 | CN101108847A (+) doxazosin mesylate, method of manufacturing the same and use thereof |
| 01/23/2008 | CN101108252A Pharmaceutical composition of cyclodextrin dragon's blood and method of preparing the same |
| 01/23/2008 | CN101108236A Hemiparalysis restoration pill and method of preparing the same |
| 01/23/2008 | CN101108230A Dií»ao xinxuekang slow release formulated product and method of preparing the same and use thereof |